eXoZymes, Inc. (EXOZ) は上場企業です ヘルスケア セクターの バイオテクノロジー 業界で事業展開. 本社所在地は Monrovia, NV, アメリカ. 現CEOは Michael Heltzen.
EXOZ を有する IPO日 2024-11-13, 31 名の正社員, に上場 NASDAQ Global Market, 時価総額 $91.91M.
eXoZymes, Inc. operates as a synthetic biochemical company in the United States. The company develops SimplePath, a platform that produces chemicals, including pharmaceuticals, fuels, materials, food additives, and novel compounds. Its platform also comprises one or more module which consist of one or more enzymes that work together to perform a defined biocatalytic conversion. The company was founded in 2014 and is headquartered in Monrovia, California.
